Esperion Therapeutics Inc (ESPR)

Short-Term Debt

$82.45M

Quarterly · Period ending: · USD

ESPR logo

ESPR Short-Term Debt

Latest reported$82.45M
ESPR Quarterly Short-Term Debt ($495.50K → $82.45M)
High-resolution chart · PNG

ESPR short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
82,445,000
91,800,000
152,073,000
123,816,000
57,492,000
57,316,000
2,741,000
2,679,000
46,025,000
36,381,000
37,931,000
23,471,000
27,531,000
25,528,000
20,329,000
23,886,000
15,826,000
14,079,000
18,852,000
14,815,000
8,693,000
2,587,000
13,557,000
11,508,000
1,913,000
454,000
267,000
199,000
184,000
0
0
152,000
603,000
1,045,000
1,479,000
1,764,000
1,737,000
1,709,000
1,682,000
1,656,000
1,629,000
1,604,000
1,578,000
1,427,000
1,030,000
638,000
253,000
0
0
0
0
0
0
15,241,007
1,052,000
1,102,000
1,081,000
1,061,000
975,000
955,000
1,067,000
863,000
952,000
1,076,000
697,000
697,000
495,000
495,000
495,495
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.